Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn’s Disease

Adalimumab Induces and Maintains Remission in Severe, Resistant Paediatric Crohn Disease

(2009) Faruk Hadziselimovic   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Safety and Efficacy of Adalimumab in Pediatric Patients With Crohn Disease

(2009) Matthew J Wyneski et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update

(2009) Ann Corken Mackey et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Combination Therapy With Infliximab and Immunomodulators: Is the Glass Half Empty?

(2008) Amar R. Deshpande et al.   GASTROENTEROLOGY

Short-term response to adalimumab in childhood inflammatory bowel disease

(2008) Joshua D. Noe et al.   INFLAMMATORY BOWEL DISEASES

Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease

(2008) Jeffrey S. Hyams et al.   INFLAMMATORY BOWEL DISEASES